← All verticals

Edition 02  ·  May 2026

Dietary Supplement Intelligence

Supplement Market
Intelligence

32 ingredients tracked across five high-growth segments. Evidence quality, velocity, and regulatory risk mapped monthly.

May 2026
01 Trend Radar

32 ingredients. Five segments. Evidence quality, maturity, and velocity in one view.

3 active red alerts 02 Monthly Pulse

Top five signals this month. Ranked by consultant relevance.

Edition 02  ·  May 2026 03 Intelligence

Nine white space opportunities. Ten brands mapped. Regulatory alerts.

Updated April 2026 04 Alerts

3 red  ·  6 amber  ·  3 green. Sorted by urgency.

6 monitoring alerts

Radar snapshot

32
Ingredients tracked
7
Fringe trends
5
Segments

Highest velocity signals this month

Moringa — Salmonella outbreak. 97 ill, 32 states. Drug-resistant second outbreak. Supply chain audit required.
Creatine (women) — CONCRET-MENOPA RCT confirms perimenopause cognitive benefits. Radar upgraded to Peak.
GLP-1 companion — 124% CAGR confirmed. First-mover branded stack position still unoccupied.
FDA disclaimer reform — Single DSHEA disclaimer per label proposed. Not yet rulemaking. FTC unaffected.

Current alerts

RedMoringa — active Salmonella outbreak, drug-resistant strain
RedBerberine GLP-1 claims — FTC enforcement risk active
RedMethylene blue — safety risk + unapproved supplement
AmberFDA DSHEA disclaimer reform — proposed, not yet rulemaking
SignalCreatine (women) — perimenopause RCT data confirmed

This edition

5 radar position changes — B-complex, Postbiotics, NMN, Creatine, Moringa
1 new ingredient added — BergacynFF (liver health / GLP-1 adjacency)
3 new alerts — Moringa RED, FDA disclaimer AMBER, Ashwagandha UK AMBER

"Evidence quality is now a commercial differentiator in supplements — not just a regulatory protection."

About Brendan Walsh →